Skip to main content
. 2024 Dec 28;43:334. doi: 10.1186/s13046-024-03258-7

Fig. 13.

Fig. 13

A Workflow of the integrated approach employed to identify determinants of ICB response. Archival tumor tissues, collected at the time of surgery, of a cohort of naïve of treatment NSCLC patients who recurred and were treated with ICB in accordance with guidelines were scored as poor (PR) and good (GR) ICB responders. Spatial transcriptomic by 10XVisium highlighted distinct composition and functionality of TLS of PR versus GR. B Standardization of organotypic tissue slices (TS) obtained from resected naïve of treatment NSCLC patients. TS were sliced, cultured, treated with ICB ex-vivo and then subjected to histological analysis. Figure created with biorender.com